e-ISSN: Pending
Negative / Null Result ReportOpen accessGynecology and obstetrics

The Value of CA125 and CA19-9 in the Diagnosis of Stage Ⅲ and Ⅳ Endometriosis

Wenwen Zhang; Huimin Tang; Qiucheng Jia; Jiming Chen; Genhai Zhu · 2024 · Clinical and Experimental Obstetrics & Gynecology

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Background: To evaluate the effect of carbohydrate antigen 125 (CA125) and CA19-9 in distinguishing stage Ⅲ and Ⅳ endometriosis from benign and malignant tumors, and to explore whether it is related to the clinical features of the disease. Methods: In a retrospective cohort study based on clinical data from hospitals, a total of 183 patients with pathologically confirmed diagnosis of ovarian endometriotic cysts (OEC) in Hainan Provincial People’s Hospital for surgical treatment from January 2019 to August 2022 were selected as the case group, and a total of 276 cases of benign diseases, includ

Abstract by Wenwen Zhang; Huimin Tang; Qiucheng Jia; Jiming Chen; Genhai Zhu, Clinical and Experimental Obstetrics & Gynecology (2024) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: DOAJ · DOI 10.31083/j.ceog5102045